{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=SARS-COV2+Infection", "query": { "condition": "SARS-COV2 Infection" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 2350, "total_pages": 235, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=SARS-COV2+Infection&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-10-04T21:08:21.102Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05946551", "title": "Treatment of Long CoronaVirus Disease (COVID) (TLC) Feasibility Trial", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "COVID-19" ], "interventions": [ { "name": "Cetirizine", "type": "DRUG" }, { "name": "Famotidine", "type": "DRUG" }, { "name": "Cetirizine Placebo", "type": "DRUG" }, { "name": "Famotidine Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 5, "start_date": "2024-03-08", "completion_date": "2024-06-24", "has_results": true, "last_update_posted_date": "2025-07-17", "last_synced_at": "2026-10-04T21:08:21.102Z", "location_count": 4, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05946551" }, { "nct_id": "NCT07079670", "title": "Safety and Immunogenicity of NVX-CoV2705", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "COVID-19", "SARS-CoV-2 Infection" ], "interventions": [ { "name": "NVX-CoV2705", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "12 Years to 90 Years" }, "enrollment_count": 676, "start_date": "2025-10-09", "completion_date": "2026-05-11", "has_results": false, "last_update_posted_date": "2026-06-05", "last_synced_at": "2026-10-04T21:08:21.102Z", "location_count": 10, "location_summary": "Phoenix, Arizona • Melrose Park, Illinois • Lenexa, Kansas + 7 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Melrose Park", "state": "Illinois" }, { "city": "Lenexa", "state": "Kansas" }, { "city": "Lafayette", "state": "Louisiana" }, { "city": "Southfield", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT07079670" }, { "nct_id": "NCT04906694", "title": "Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (US)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Covid19" ], "interventions": [ { "name": "COVI-DROPS", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Sorrento Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 97, "start_date": "2021-11-16", "completion_date": "2022-01-13", "has_results": false, "last_update_posted_date": "2022-02-03", "last_synced_at": "2026-10-04T21:08:21.102Z", "location_count": 18, "location_summary": "Colorado Springs, Colorado • Jacksonville, Florida • Miami, Florida + 15 more", "locations": [ { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04906694" }, { "nct_id": "NCT04734873", "title": "CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Covid-19" ], "interventions": [ { "name": "CPI-006 2 mg/kg + SOC", "type": "DRUG" }, { "name": "CPI-006 1 mg/kg + SOC", "type": "DRUG" }, { "name": "Placebo + SOC", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Corvus Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 46, "start_date": "2021-02-25", "completion_date": "2021-08-18", "has_results": true, "last_update_posted_date": "2022-09-21", "last_synced_at": "2026-10-04T21:08:21.102Z", "location_count": 13, "location_summary": "Chula Vista, California • El Centro, California • La Mesa, California + 10 more", "locations": [ { "city": "Chula Vista", "state": "California" }, { "city": "El Centro", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04734873" }, { "nct_id": "NCT06417762", "title": "Dime La VerDAD: Verify, Debunk, and Disseminate", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Influenza", "COVID-19", "Communication Research", "Health Behavior", "Respiratory Viral Infection" ], "interventions": [ { "name": "Science Communication Curriculum Cohort 1", "type": "BEHAVIORAL" }, { "name": "Science communication curriculum Cohort 2", "type": "BEHAVIORAL" }, { "name": "Science communication curriculum Cohort 3", "type": "BEHAVIORAL" }, { "name": "Science communication curriculum Cohort 4", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 1400, "start_date": "2024-07-02", "completion_date": "2029-04-01", "has_results": false, "last_update_posted_date": "2026-08-26", "last_synced_at": "2026-10-04T21:08:21.102Z", "location_count": 4, "location_summary": "Chicago, Illinois • Iowa City, Iowa • Ann Arbor, Michigan", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT06417762" }, { "nct_id": "NCT05541861", "title": "Safety and Effects of an Investigational COVID-19 Vaccine as Booster in Healthy People", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "SARS-CoV-2 Infection", "COVID-19" ], "interventions": [ { "name": "BNT162b2 Bivalent (original/Omicron BA.4/BA.5) 30 mcg", "type": "BIOLOGICAL" }, { "name": "BNT162b4 5 mcg", "type": "BIOLOGICAL" }, { "name": "BNT162b4 10 mcg", "type": "BIOLOGICAL" }, { "name": "BNT162b4 15 mcg", "type": "BIOLOGICAL" }, { "name": "BNT162b4 30 mcg", "type": "BIOLOGICAL" }, { "name": "BNT162b2 Monovalent (OMI XBB.1.5) 30 mcg", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "BioNTech SE", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 383, "start_date": "2022-11-08", "completion_date": "2024-11-22", "has_results": true, "last_update_posted_date": "2026-01-13", "last_synced_at": "2026-10-04T21:08:21.102Z", "location_count": 17, "location_summary": "Tempe, Arizona • Newport Beach, California • San Diego, California + 13 more", "locations": [ { "city": "Tempe", "state": "Arizona" }, { "city": "Newport Beach", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Milford", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT05541861" }, { "nct_id": "NCT04927845", "title": "StriveWeekly Online Mental Health Trial Post-pandemic", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Anxiety", "Depressive Symptoms", "Stress, Emotional" ], "interventions": [ { "name": "StriveWeekly", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Harvard University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "ALL", "summary": "16 Years and older" }, "enrollment_count": 538, "start_date": "2021-05-19", "completion_date": "2022-06-10", "has_results": true, "last_update_posted_date": "2024-09-03", "last_synced_at": "2026-10-04T21:08:21.102Z", "location_count": 1, "location_summary": "Cambridge, Massachusetts", "locations": [ { "city": "Cambridge", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04927845" }, { "nct_id": "NCT05040659", "title": "Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Anosmia", "Asymptomatic COVID-19", "COVID-19 Respiratory Infection", "Influenza", "Healthy", "PASC Post Acute Sequelae of COVID 19" ], "interventions": [ { "name": "AROMHA Longitudinal Smell Test", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 1000, "start_date": "2022-11-14", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2026-03-06", "last_synced_at": "2026-10-04T21:08:21.102Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05040659" }, { "nct_id": "NCT04569786", "title": "Dose Ranging Trial to Assess Safety and Immunogenicity of V590 (COVID-19 Vaccine) in Healthy Adults (V590-001)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Coronavirus Disease (COVID-19)" ], "interventions": [ { "name": "V590", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 232, "start_date": "2020-10-29", "completion_date": "2021-02-18", "has_results": true, "last_update_posted_date": "2021-12-29", "last_synced_at": "2026-10-04T21:08:21.102Z", "location_count": 7, "location_summary": "Tempe, Arizona • Miami, Florida • South Miami, Florida + 4 more", "locations": [ { "city": "Tempe", "state": "Arizona" }, { "city": "Miami", "state": "Florida" }, { "city": "South Miami", "state": "Florida" }, { "city": "Springfield", "state": "Missouri" }, { "city": "Lincoln", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT04569786" }, { "nct_id": "NCT04561102", "title": "Evaluation of the COVIDSeq Test in Nasal Swab and Saliva From a COVID-19 Asymptomatic Population", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "SARS-CoV-2" ], "interventions": [ { "name": "Diagnostic test for detection of SARS-CoV-2", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Illumina, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 644, "start_date": "2020-09-11", "completion_date": "2021-02-28", "has_results": false, "last_update_posted_date": "2022-01-21", "last_synced_at": "2026-10-04T21:08:21.102Z", "location_count": 1, "location_summary": "Winter Park, Florida", "locations": [ { "city": "Winter Park", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04561102" } ] }